Pharyngitis Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026

Published on : Dec-2017 | List of Tables : 146 | List of Figures : 90 | No. of Pages : 170 | Report Code : FACT361MR | Format : ppt pdf Excel Word

Pharyngitis commonly known as a sore throat is caused by viral or bacterial infection. The most common bacteria infecting throat is Group A streptococcus. Various clinical trials are being carried on to find the best formulation effective in treating sore throat. There is also a focus on patients receiving medication as per the clinical needs and also meet their individual requirement. The healthcare industry across the globe is also emphasizing on appropriate diagnosis, drug selection, dosage, drug delivery route, duration of administration, proper follow-up, and correct information on possible side-effects.

global pharyngitis  market

The latest study by Fact.MR expects the global market for pharyngitis to experience sluggish growth. Towards 2026 end, the global market for pharyngitis is projected to bring in US$ 1,679.0 million revenue. Pharyngitis is the most common manifestation of infection. Antibiotics are given in case of a sore throat, however, they provide very modest benefit. It is still unclear which antibiotic is the best for the treatment of a sore throat. Hence, various research and trials are being conducted to find most effective antibiotic.

Market Taxonomy

Drug Class

Distribution Channel

Mode of Delivery

Beta Lactams

Hospital Pharmacies

Oral

Macrolides

Retail Pharmacies and Drug Stores

Intravenous

Cephalosporins

Online Pharmacies

Intramuscular

Fluoroquinolones

 

Other Mode of Delivery

Tetracycline

 

 

Other Products

 

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Beta Lactams to Emerge as the Most-Preferred Drug Class

Compared to the various drug class, beta lactams is likely to emerge as one of the most preferred drug class between 2017 and 2026. Beta lactams is projected to bring in nearly US$ 500 million revenue by 2026 end. Beta-lactams include cephalosporins and penicillins. These drugs are active against many harmful organisms. Moreover, the recent development of broad-spectrum beta-lactams antibiotics active against gram-negative organisms has increased their use.

Retail Pharmacies and Drug Stores to Emerge as the Biggest Distribution Channel

Retail pharmacies and drug stores are likely to gain maximum revenue share. By 2026 end, retail pharmacies and drug stores are projected to bring in nearly US$ 700 million revenue. A sore throat is very common, pharmacists can assess specific symptoms as described by patients and based on it can suggest Over the Counter (OTC) drug that available at retail pharmacies and drug stores. One of the most commonly used OTC products for treating sore throat is lozenges. Moreover, pharmaceutical companies are also introducing new products that can offer rapid relief in pain.

Oral Drug Delivery to Gain Maximum Traction between 2017 and 2026

Oral drug delivery is likely to emerge as the most-preferred drug administration route. Oral drug delivery is projected to create an incremental opportunity of over US$ 300 million between 2017 and 2026. Owing to the cost-effectiveness, convenience and high patient compliance, oral drug delivery is witnessing significant growth. However, many drugs are poorly bioavailable when administered. Hence, lipid-based drug delivery system is one of the emerging trends addressing bioavailability challenges. Moreover, oral drug delivery is the least invasive method as compared to other routes. Targeted drug delivery is also an emerging trend, in which the drug is active only in the targeted area.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global pharyngitis market through 2026, which include Pfizer Inc., GlaxoSmithKline PLC, Novartis AG, BioStar Pharmaceuticals, Inc., and Zambon Group SpA.  

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

1. Global Economic Outlook

2. Global Pharyngitis Market - Executive Summary

3. Global Pharyngitis Market Overview
3.1. Introduction
       3.1.1. Global Pharyngitis Market Taxonomy
       3.1.2. Global Pharyngitis Market Definition
3.2. Global Pharyngitis Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Pharyngitis Market Y-o-Y Growth
3.3. Global Pharyngitis Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis 
3.7. Drug Pipeline Assessment
3.8. Product Life Cycle
3.9. PEST Analysis

4. Global Pharyngitis Market Analysis and Forecast 2012-2026 
4.1. Global Pharyngitis Market Size and Forecast By Drug Class, 2012-2026
       4.1.1. Beta Lactams Market Size and Forecast, 2012-2026
                4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
       4.1.2. Macrolides Market Size and Forecast, 2012-2026
                4.1.2.1. Revenue (US$ Mn) Comparison, By Region
                4.1.2.2. Market Share Comparison, By Region
                4.1.2.3. Y-o-Y growth Comparison, By Region
       4.1.3. Cephalosporins Market Size and Forecast, 2012-2026
                4.1.3.1. Revenue (US$ Mn) Comparison, By Region
                4.1.3.2. Market Share Comparison, By Region
                4.1.3.3. Y-o-Y growth Comparison, By Region
       4.1.4. Fluoroquinolones Market Size and Forecast, 2012-2026
                4.1.4.1. Revenue (US$ Mn) Comparison, By Region
                4.1.4.2. Market Share Comparison, By Region
                4.1.4.3. Y-o-Y growth Comparison, By Region
       4.1.5. Tetracycline Market Size and Forecast, 2012-2026
                4.1.5.1. Revenue (US$ Mn) Comparison, By Region
                4.1.5.2. Market Share Comparison, By Region
                4.1.5.3. Y-o-Y growth Comparison, By Region
       4.1.6. Other Products Market Size and Forecast, 2012-2026
                4.1.6.1. Revenue (US$ Mn) Comparison, By Region
                4.1.6.2. Market Share Comparison, By Region
                4.1.6.3. Y-o-Y growth Comparison, By Region
4.2. Global Pharyngitis Market Size and Forecast By Distribution Channel, 2012-2026
       4.2.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
                4.2.1.1. Revenue (US$ Mn) Comparison, By Region
                4.2.1.2. Market Share Comparison, By Region
                4.2.1.3. Y-o-Y growth Comparison, By Region
       4.2.2. Retail Pharmacies and Drug Stores Market Size and Forecast, 2012-2026
                4.2.2.1. Revenue (US$ Mn) Comparison, By Region
                4.2.2.2. Market Share Comparison, By Region
                4.2.2.3. Y-o-Y growth Comparison, By Region
       4.2.3. Online Pharmacies Market Size and Forecast, 2012-2026
                4.2.3.1. Revenue (US$ Mn) Comparison, By Region
                4.2.3.2. Market Share Comparison, By Region
                4.2.3.3. Y-o-Y growth Comparison, By Region
4.3. Global Pharyngitis Market Size and Forecast By Mode of Delivery, 2012-2026
       4.3.1. Oral Market Size and Forecast, 2012-2026
                4.3.1.1. Revenue (US$ Mn) Comparison, By Region
                4.3.1.2. Market Share Comparison, By Region
                4.3.1.3. Y-o-Y growth Comparison, By Region
       4.3.2. Intravenous Market Size and Forecast, 2012-2026
                4.3.2.1. Revenue (US$ Mn) Comparison, By Region
                4.3.2.2. Market Share Comparison, By Region
                4.3.2.3. Y-o-Y growth Comparison, By Region
       4.3.3. Intramuscular Market Size and Forecast, 2012-2026
                4.3.3.1. Revenue (US$ Mn) Comparison, By Region
                4.3.3.2. Market Share Comparison, By Region
                4.3.3.3. Y-o-Y growth Comparison, By Region
       4.3.4. Other Mode of Delivery Market Size and Forecast, 2012-2026
                4.3.4.1. Revenue (US$ Mn) Comparison, By Region
                4.3.4.2. Market Share Comparison, By Region
                4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Pharyngitis Market Size and Forecast, 2012-2026
5.1. North America Outlook 
5.2. North America Parent Market Outlook 
5.3. North America Target Market Outlook 
5.4. Revenue (US$ Mn) Comparison, By Country 
       5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
       5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Drug Class 
5.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
5.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

6. Latin America Pharyngitis Market Size and Forecast, 2012-2026
6.1. Latin America Outlook 
6.2. Latin America Parent Market Outlook 
6.3. Latin America Target Market Outlook 
6.4. Revenue (US$ Mn) Comparison, By Country 
       6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
       6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
       6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Drug Class 
6.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
6.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

7. Europe Pharyngitis Market Size and Forecast, 2012-2026
7.1. Europe Outlook 
7.2. Europe Parent Market Outlook 
7.3. Europe Target Market Outlook 
7.4. Revenue (US$ Mn) Comparison, By Country 
       7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
       7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
       7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
       7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
       7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
       7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Drug Class 
7.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
7.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

8. Japan Pharyngitis Market Size and Forecast, 2012-2026
8.1. Japan Outlook 
8.2. Japan Parent Market Outlook 
8.3. Japan Target Market Outlook 
8.4. Revenue (US$ Mn) Comparison, By Country 
       8.4.1. Japan  Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Drug Class 
8.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
8.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

9. APEJ Pharyngitis Market Size and Forecast, 2012-2026
9.1. APEJ Outlook 
9.2. APEJ Parent Market Outlook 
9.3. APEJ Target Market Outlook 
9.4. Revenue (US$ Mn) Comparison, By Country 
       9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
       9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
       9.4.3. Australia Market Size and Forecast (US$ Mn), 2012-2026
       9.4.4. Thailand Market Size and Forecast (US$ Mn), 2012-2026
       9.4.5. Singapore Market Size and Forecast (US$ Mn), 2012-2026
       9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Drug Class 
9.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
9.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

10. MEA Pharyngitis Market Size and Forecast, 2012-2026
10.1. MEA Outlook 
10.2. MEA Parent Market Outlook 
10.3. MEA Target Market Outlook 
10.4. Revenue (US$ Mn) Comparison, By Country 
       10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
       10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
       10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
       10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Drug Class 
10.6. Revenue (US$ Mn) Comparison, By Distribution Channel 
10.7. Revenue (US$ Mn) Comparison, By Mode of Delivery 

11. Global Pharyngitis Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
       11.3.1. GlaxoSmithKline PLC
       11.3.2. Pfizer Inc.
       11.3.3. Teva Pharmaceutical Industries Limited
       11.3.4. Merck KGaA
       11.3.5. Sanofi
       11.3.6. Abbott Laboratories Inc.
       11.3.7. Novartis AG
       11.3.8. Zambon Group SpA
       11.3.9. BioStar Pharmaceuticals, Inc.

12. Research Methodology

13. Secondary and Primary Sources

14. Assumptions and Acronyms

15. Disclaimer

List of Table

TABLE 1 Global Pharyngitis Market Value (US$ Mn), 2012-2017
TABLE 2 Global Pharyngitis Market Value (US$ Mn), 2018-2026
TABLE 3 Global Pharyngitis Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Beta Lactams Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Beta Lactams Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Beta Lactams Segment Market Share, By Region 2012-2017
TABLE 7 Global Beta Lactams Segment Market Share, By Region 2018-2026
TABLE 8 Global Beta Lactams Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Macrolides Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Macrolides Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Macrolides Segment Market Share, By Region 2012-2017
TABLE 12 Global Macrolides Segment Market Share, By Region 2018-2026
TABLE 13 Global Macrolides Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Cephalosporins Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Cephalosporins Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Cephalosporins Segment Market Share, By Region 2012-2017
TABLE 17 Global Cephalosporins Segment Market Share, By Region 2018-2026
TABLE 18 Global Cephalosporins Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Fluoroquinolones Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Fluoroquinolones Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Fluoroquinolones Segment Market Share, By Region 2012-2017
TABLE 22 Global Fluoroquinolones Segment Market Share, By Region 2018-2026
TABLE 23 Global Fluoroquinolones Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Tetracycline Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Tetracycline Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Tetracycline Segment Market Share, By Region 2012-2017
TABLE 27 Global Tetracycline Segment Market Share, By Region 2018-2026
TABLE 28 Global Tetracycline Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Other Products Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Other Products Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Other Products Segment Market Share, By Region 2012-2017
TABLE 32 Global Other Products Segment Market Share, By Region 2018-2026
TABLE 33 Global Other Products Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 37 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 38 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Retail Pharmacies and Drug Stores Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2012-2017
TABLE 42 Global Retail Pharmacies and Drug Stores Segment Market Share, By Region 2018-2026
TABLE 43 Global Retail Pharmacies and Drug Stores Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 47 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 48 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Oral Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Oral Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Oral Segment Market Share, By Region 2012-2017
TABLE 52 Global Oral Segment Market Share, By Region 2018-2026
TABLE 53 Global Oral Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Intravenous Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Intravenous Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Intravenous Segment Market Share, By Region 2012-2017
TABLE 57 Global Intravenous Segment Market Share, By Region 2018-2026
TABLE 58 Global Intravenous Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Intramuscular Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Intramuscular Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Intramuscular Segment Market Share, By Region 2012-2017
TABLE 62 Global Intramuscular Segment Market Share, By Region 2018-2026
TABLE 63 Global Intramuscular Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Other Mode of Delivery Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Other Mode of Delivery Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Other Mode of Delivery Segment Market Share, By Region 2012-2017
TABLE 67 Global Other Mode of Delivery Segment Market Share, By Region 2018-2026
TABLE 68 Global Other Mode of Delivery Segment Y-o-Y, By Region 2017-2026
TABLE 69 North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 70 North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 71 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 72 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 73 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 74 North America Pharyngitis Market Value (US$ Mn), By Country 2012-2017
TABLE 75 North America Pharyngitis Market Value (US$ Mn), By Country 2018-2026
TABLE 76 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 77 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 78 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 79 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 80 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
TABLE 81 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
TABLE 82 Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 83 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 84 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 85 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 86 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 87 Latin America Pharyngitis Market Value (US$ Mn), By Country 2012-2017
TABLE 88 Latin America Pharyngitis Market Value (US$ Mn), By Country 2018-2026
TABLE 89 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 90 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 91 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 92 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 93 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
TABLE 94 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
TABLE 95 Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 96 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 97 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 98 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 99 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 100 Europe Pharyngitis Market Value (US$ Mn), By Country 2012-2017
TABLE 101 Europe Pharyngitis Market Value (US$ Mn), By Country 2018-2026
TABLE 102 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 103 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 104 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 105 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 106 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
TABLE 107 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
TABLE 108 Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 109 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 110 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 111 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 112 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 113 Japan Pharyngitis Market Value (US$ Mn), By Country 2012-2017
TABLE 114 Japan Pharyngitis Market Value (US$ Mn), By Country 2018-2026
TABLE 115 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 116 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 117 Japan Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 118 Japan Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 119 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
TABLE 120 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
TABLE 121 APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 122 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 123 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 124 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 125 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 126 APEJ Pharyngitis Market Value (US$ Mn), By Country 2012-2017
TABLE 127 APEJ Pharyngitis Market Value (US$ Mn), By Country 2018-2026
TABLE 128 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 129 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 130 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 131 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 132 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
TABLE 133 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
TABLE 134 MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 135 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 136 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 137 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 138 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 139 MEA Pharyngitis Market Value (US$ Mn), By Country 2012-2017
TABLE 140 MEA Pharyngitis Market Value (US$ Mn), By Country 2018-2026
TABLE 141 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 142 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 143 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 144 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 145 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
TABLE 146 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

List of Figure

FIG. 1 Global Pharyngitis Market Value (US$ Mn), 2012-2017
FIG. 2 Global Pharyngitis Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Pharyngitis Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Beta Lactams Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Beta Lactams Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Beta Lactams Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Macrolides Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Macrolides Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Macrolides Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Cephalosporins Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Cephalosporins Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Cephalosporins Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Fluoroquinolones Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Fluoroquinolones Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Fluoroquinolones Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Tetracycline Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Tetracycline Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Tetracycline Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Other Products Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Other Products Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Other Products Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Retail Pharmacies and Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Retail Pharmacies and Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Intravenous Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Intravenous Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Intravenous Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Intramuscular Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Intramuscular Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Intramuscular Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Other Mode of Delivery Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Other Mode of Delivery Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Other Mode of Delivery Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 North America Pharyngitis Market Value (US$ Mn), By Country 2012-2017
FIG. 44 North America Pharyngitis Market Value (US$ Mn), By Country 2018-2026
FIG. 45 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 46 North America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 47 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 48 North America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 49 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 50 North America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
FIG. 51 Latin America Pharyngitis Market Value (US$ Mn), By Country 2012-2017
FIG. 52 Latin America Pharyngitis Market Value (US$ Mn), By Country 2018-2026
FIG. 53 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 54 Latin America Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 55 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 56 Latin America Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 57 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 58 Latin America Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
FIG. 59 Europe Pharyngitis Market Value (US$ Mn), By Country 2012-2017
FIG. 60 Europe Pharyngitis Market Value (US$ Mn), By Country 2018-2026
FIG. 61 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 62 Europe Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 63 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 64 Europe Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 65 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 66 Europe Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
FIG. 67 Japan Pharyngitis Market Value (US$ Mn), By Country 2012-2017
FIG. 68 Japan Pharyngitis Market Value (US$ Mn), By Country 2018-2026
FIG. 69 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 70 Japan Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 71 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 72 Japan Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 73 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 74 Japan Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
FIG. 75 APEJ Pharyngitis Market Value (US$ Mn), By Country 2012-2017
FIG. 76 APEJ Pharyngitis Market Value (US$ Mn), By Country 2018-2026
FIG. 77 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 78 APEJ Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 79 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 80 APEJ Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 81 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 82 APEJ Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026
FIG. 83 MEA Pharyngitis Market Value (US$ Mn), By Country 2012-2017
FIG. 84 MEA Pharyngitis Market Value (US$ Mn), By Country 2018-2026
FIG. 85 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 86 MEA Pharyngitis Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 87 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 88 MEA Pharyngitis Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 89 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2012-2017
FIG. 90 MEA Pharyngitis Market Value (US$ Mn), By Mode of Delivery 2018-2026

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Pharyngitis Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2017 to 2026